HBsAg and HBV DNA levels guiding entecavir cessation in HBeAg-negative chronic hepatitis B

被引：0
|
作者：
Seto, Wai-Kay
Hui, Aric Josun
Wong, Vincent Wai-Sun
Wong, Grace Lai-Hung
Liu, Kevin
Lai, Ching-Lung
Yuen, Man-Fung
Chan, Henry Lik-Yuen
机构：
[1] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
[2] Alice Ho Miu Ling Nethersole Hosp, Hong Kong, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
hepatitis B; nucleoside analogue; treatment cessation; HBsAg;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：414 / 414
页数：1
相关论文
共 50 条
  • [21] Pretreatment HBsAg serum levels predict HBsAg seroconversion in HBeAg-negative chronic hepatitis B (CHBe-) patients
    Manesis, EK
    Hadziyannis, ES
    Angelopoulou, OP
    Hadziyannis, SJ
    HEPATOLOGY, 2005, 42 (04) : 590A - 590A
  • [22] Correlation between entecavir penetration in peripheral blood mononuclear cells and HBV DNA decay during treatment of HBeAg-negative chronic hepatitis B
    De Nicolo, Amedeo
    Boglione, Lucio
    Cusato, Jessica
    Fatiguso, Giovanna
    Favata, Fabio
    Allegra, Sarah
    Cariti, Giuseppe
    Di Perri, Giovanni
    D'Avolio, Antonio
    ANTIVIRAL THERAPY, 2018, 23 (04) : 373 - 377
  • [23] Commentary: HBsAg levels as predictor of sustained response to peg interferon in HBeAg-negative chronic hepatitis B
    Hadziyannis, S. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (07) : 842 - 843
  • [24] Comparisons of HBsAg Change and HBsAg Loss between Hbeag-Negative Patients Chronic Hepatitis B Patients Who Discontinued Entecavir and Those Who Continued Entecavir Therapy
    Chen, Chien Hung
    Peng, Cheng-Yuan
    Hu, Tsung-Hui
    Wang, Jing-Houng
    HEPATOLOGY, 2018, 68 : 267A - 267A
  • [25] Treatment of HBeAg-negative chronic hepatitis B
    Hadziyannis, SJ
    Papatheodoridis, GV
    Vassilopoulos, D
    SEMINARS IN LIVER DISEASE, 2003, 23 (01) : 81 - 88
  • [26] Editorial: HBsAg serum levels in HBeAg-negative chronic HBV infection-is it a matter of genotype?
    Alexopoulou, A.
    Karayiannis, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (01) : 102 - 103
  • [27] Longitudinal changes in serum HBV-DNA levels during the natural course of HBeAg-negative chronic hepatitis B virus (HBV) infection
    Papatheodoridis, G. V.
    Sevastianos, V.
    Panopoulou, H.
    Chrysanthos, N.
    Hadziyannis, E.
    Cholongitas, E.
    Laras, A.
    Manesis, E. K.
    Hadziyannis, S. J.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S182 - S182
  • [28] Discordant serum HBV DNA and RNA correlation with quantitative HBsAg and high levels of intrahepatic integrated HBV DNA in HBeAg negative chronic hepatitis B
    Lau, Daryl
    Kim, Elena
    Bai, Chosha
    King, Wendy C.
    Cui, Yixiao
    Kleiner, David E.
    Ghany, Marc
    Nguyen, Thi Thuy Tu
    Hinerman, Amanda S.
    Wang, Zhili
    Chung, Raymond
    Sterling, Richard
    Cloherty, Gavin
    Su, Ying-Hsiu
    Guo, Haitao
    JOURNAL OF HEPATOLOGY, 2022, 77 : S264 - S264
  • [29] Correlation Between HBsAg Quantitation and HBV DNA in HBeAg-Negative HBV/D Patients
    Teriaky, Anouar
    Al-Judaibi, Bandar
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2013, 19 (06): : 243 - 244
  • [30] Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B
    Moutinho, Renata S.
    Perez, Renata M.
    Medina-Pestana, Jose O.
    Figueiredo, Mauro S.
    Koide, Sandra
    Alberto, Fernando Lopes
    Silva, Antonio Eduardo B.
    Ferraz, Maria Lucia G.
    JOURNAL OF MEDICAL VIROLOGY, 2006, 78 (10) : 1284 - 1288
12345